Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-426.88	-11.93	-108.14
Depreciation & Amortization	0.83	2.35	2.13
Other Amortization	40.97	33.51	23.84
Loss (Gain) From Sale of Investments	0.65	0.54	-10.76
Stock-Based Compensation	591.12	0.74	1.65
Provision & Write-off of Bad Debts	5.7	5.41	4.86
Other Operating Activities	-101.15	4.88	13.11
Change in Accounts Receivable	-37.64	-1.34	-23.13
Change in Inventory	-3.64	0.61	10.57
Change in Accounts Payable	3.68	-10.98	11.56
Change in Unearned Revenue	87.73	77.16	35.97
Change in Other Net Operating Assets	-69.48	-51.95	-25.56
Operating Cash Flow	91.89	49	-63.91
Capital Expenditures	-0.72	-1.04	-1.98
Sale (Purchase) of Intangibles	-3.75	-2.73	-2.64
Investment in Securities	-9.42	22.09	6.12
Investing Cash Flow	-17.9	18.31	1.5
Issuance of Common Stock	256.26	0.61	0.49
Other Financing Activities	-57.81	-2.81	-3.49
Financing Cash Flow	-73.81	-2.2	-3
Net Cash Flow	0.18	65.11	-65.41
Free Cash Flow	91.17	47.96	-65.89
Free Cash Flow Margin	18.96%	12.29%	-22.51%
Free Cash Flow Per Share	4.16	3.54	-5.06
Levered Free Cash Flow	-	73.18	-
Unlevered Free Cash Flow	-	73.18	-
Change in Working Capital	-19.35	13.5	9.41

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q